| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 10/17/2002 | WO2002081028A2 Cytoprotection by phosphotyrosine |
| 10/17/2002 | WO2002080949A1 Use of extracts of the plant litchi chinensis sonn. |
| 10/17/2002 | WO2002080943A1 Zinc ionophores as anti-stress agents |
| 10/17/2002 | WO2002080942A1 Pharmaceutical composition comprising copper, salicyclic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection |
| 10/17/2002 | WO2002080676A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 10/17/2002 | WO2002070524A3 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 10/17/2002 | WO2002047493A3 Health promoting compositions |
| 10/17/2002 | WO2002036605A9 Estrone-derivatives having cytoprotective activity |
| 10/17/2002 | WO2002029061A3 G-protein coupled receptors |
| 10/17/2002 | WO2002015920A3 Treatment of hyperproliferative diseases |
| 10/17/2002 | WO2001058241A9 Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 10/17/2002 | US20020150565 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 10/17/2002 | DE10117834A1 Zytoprotektion durch Phosphotyrosin Cytoprotection by phosphotyrosine |
| 10/17/2002 | CA2443025A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 10/17/2002 | CA2442858A1 Zinc ionophores as anti-stress agents |
| 10/16/2002 | EP1249241A1 Adsorbent for oral administration |
| 10/16/2002 | EP1248801A1 Human polynucleotides, polypeptides, and antibodies |
| 10/16/2002 | EP1248624A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 10/16/2002 | CN1374128A Jiudanhuanxincao herb capsule |
| 10/15/2002 | US6465504 Such as 4-(3,5-bis(2-hydroxyphenyl)-(1,2,4)triazol-1-yl)-benzoic acid; treatment of iron overload by mobilizing and eliminating iron deposits; preventing organ damage, in particular of liver, heart and endocrine organs |
| 10/15/2002 | US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor |
| 10/15/2002 | US6465435 Prevention and/or treatment of antibiotic associated diarrhea or pseudomembranous colitis; binding and eliminating toxins a and b from gastrointestinal tract using oligosaccharide sequence attached to inert support by nonpetidyl linker |
| 10/15/2002 | CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
| 10/15/2002 | CA2091766C Enhancement of glutathione levels with glutamine |
| 10/10/2002 | WO2002078726A1 Proteotoxin neutralizer |
| 10/10/2002 | WO2002078682A2 Estrogen replacement therapy |
| 10/10/2002 | WO2002078627A2 N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity |
| 10/10/2002 | WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents |
| 10/10/2002 | US20020147234 Nitrate esters and methods of making same |
| 10/10/2002 | US20020147213 Side effect reduction; synergistic mixture |
| 10/10/2002 | US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same |
| 10/10/2002 | US20020147137 Medical use of alpha1-acid glycoprotein (AAG) or orosomucoid |
| 10/10/2002 | US20020147131 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissue |
| 10/10/2002 | US20020146463 Useful as food additives or in medicaments |
| 10/10/2002 | US20020146462 Anti-tumor therapies comprising a combination of a cartilage extract and an anti-neoplastic agent providing high efficacy and low toxic side effects |
| 10/10/2002 | DE10116589A1 Use of creatine for reducing oxidative stress e.g. for treating aging, neurodegeneration and cancers |
| 10/10/2002 | CA2442798A1 Antioxidant nitroxides and nitrones as therapeutic agents |
| 10/10/2002 | CA2441252A1 Estrogen replacement therapy |
| 10/09/2002 | EP1247527A1 Cosmetic and/or pharmaceutical preparations containing extracts of the plant Litchi chinensis Sonn |
| 10/09/2002 | EP1246919A1 Progenitor cell preservation factors and related methods and products |
| 10/09/2002 | EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
| 10/09/2002 | EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 10/09/2002 | EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions |
| 10/09/2002 | EP1246629A1 Methods of using electron active compounds for managing cancer |
| 10/09/2002 | CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs. |
| 10/09/2002 | CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 10/09/2002 | CN1092053C Process for preparing active aloe powder |
| 10/08/2002 | US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome |
| 10/08/2002 | US6462024 Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart |
| 10/03/2002 | WO2002077174A2 Human cytokine receptor |
| 10/03/2002 | WO2002076494A2 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS |
| 10/03/2002 | WO2002076443A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 10/03/2002 | WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 10/03/2002 | WO2001021812A9 Phosphatases which activate map kinase pathways |
| 10/03/2002 | US20020143060 Preventing active oxygen injury by of citrulline to decrease active oxygen content |
| 10/03/2002 | US20020142995 To enhance the ability of mammalian red blood cells to deliver oxygen, by delivering ligand for the allosteric site of hemoglobin to the cytoplasm of the red blood cells |
| 10/03/2002 | US20020142991 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine |
| 10/03/2002 | CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders |
| 10/03/2002 | CA2439961A1 Human cytokine receptor |
| 10/02/2002 | EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 10/02/2002 | EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 10/02/2002 | EP0936915B1 Chelating agents and their metal chelates for treating free radicals induced conditions |
| 10/02/2002 | CN1372562A Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 10/02/2002 | CN1371993A Superoxide dismutase conjugated substance and preparation method thereof |
| 10/02/2002 | CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method |
| 09/26/2002 | WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074346A2 Targeting chemical compounds to cells |
| 09/26/2002 | WO2002074343A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 09/26/2002 | WO2002074292A2 Hormone replacement therapy |
| 09/26/2002 | WO2002074104A1 Foods containing young wheat leaf powder |
| 09/26/2002 | WO2002056755A3 Method for treating cancer |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
| 09/26/2002 | WO2001019823A9 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 09/26/2002 | US20020137923 Per-(3,6-anhydro)cyclodextrins derivatives, preparation and use thereof for separating ions |
| 09/26/2002 | US20020137689 Hypolipidemic agents |
| 09/26/2002 | US20020136819 Conserved concentrations of cocoa polyphenols by mixing carbohydrate or protein containing ingredients with a polyphenol conserving pretreatment ingredient and then with a cocoa polyphenol |
| 09/26/2002 | US20020136786 Composition and method for smoke detoxification |
| 09/26/2002 | CA2441152A1 Hormone replacement therapy |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/25/2002 | EP1243586A1 Phloridzin-rich phenolic fraction and its use as cosmetic, food or nutritional agent |
| 09/25/2002 | EP1243272A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 09/25/2002 | CN1370776A Separating prepn process of gallo catechin and gallate |
| 09/25/2002 | CN1091379C Detoxicating instant particles and preparing method thereof |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | WO2001019360A3 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 09/19/2002 | US20020132842 Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them |